US Stock MarketDetailed Quotes

GMAB Genmab

Watchlist
  • 29.650
  • -0.570-1.89%
Close May 16 16:00 ET
  • 29.650
  • 0.0000.00%
Post 16:00 ET
19.15BMarket Cap24.48P/E (TTM)

Genmab Key Stats

Genmab Earnings Date

Currency: DKK

Period

Q1 FY2024 Earnings

May 2, 2024

Revenue(YoY)

4.14B

+46.19%
EPS(YoY)

2.02

+532.60%

Buy

May 16, 2024

Genmab Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 12 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: DKK

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
Nov 6, 20242024/Q3-- / 5.286B--
Aug 1, 20242024/Q2-- / 4.992B--
May 2, 20242024/Q14.143B / 3.954B--
Feb 14, 20242023/Q44.678B / 4.610B--
Nov 7, 20232023/Q34.744B / 4.474B--
Aug 3, 20232023/Q24.198B / 4.070B--
May 10, 20232023/Q12.854B / 2.809B--
Feb 22, 20232022/Q45.227B / 4.727B--
Nov 9, 20222022/Q34.087B / 3.634B--
Aug 10, 20222022/Q23.162B / 2.833B--
DatePeriodRevenue/EstimateEarnings Call
Nov 6, 20242024/Q3-- / 5.286B--
Aug 1, 20242024/Q2-- / 4.992B--
May 2, 20242024/Q14.143B / 3.954B--
Feb 14, 20242023/Q44.678B / 4.610B--
Nov 7, 20232023/Q34.744B / 4.474B--
Aug 3, 20232023/Q24.198B / 4.070B--
May 10, 20232023/Q12.854B / 2.809B--
Feb 22, 20232022/Q45.227B / 4.727B--
Nov 9, 20222022/Q34.087B / 3.634B--
Aug 10, 20222022/Q23.162B / 2.833B--

Unlock Free Earnings Estimates

Genmab Earnings Reports

Read more

Analysis

Analyst Rating

Updated: May 16, 2024

Buy

  • Buy

    57.14%
  • Hold

    42.86%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg